Available IPD datapackage for study 'A Phase 3 Clinical Study to Determine the Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor : Recombinant Factor VIII (rVWF:rFVIII) and rVWF in the Treatment of Bleeding Episodes in Subjects Diagnosed With Von Willebrand Disease'

The purpose of this Phase 3 study is to assess the pharmacokinetics of rVWF:rFVIII and rVWF,
and to assess the safety and efficacy of rVWF:rFVIII and rVWF in the treatment of bleeding
events in subjects with severe hereditary von Willebrand disease (VWD).